Malignant Solid Neoplasm
📧 Sign up to get email alerts when something new happens for Malignant Solid Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors [NA]
Clinical trial update for an eHealth diet and physical activity program among rural Latino cancer survivors; the study is terminated with re…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 trial update on entinostat in pediatric patients with recurrent or refractory solid tumors, completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab with or without ipilimumab in younger patients with recurrent or refractory solid tumors or sarcomas; c…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus [Phase 1]
Phase 1 trial evaluating cabozantinib malate in patients with advanced solid tumors and HIV infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial studying pevonedistat with pembrolizumab for dMMR/MSI-H metastatic or locally advanced unresectable solid tumors; trial term…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating adavosertib in combination with irinotecan hydrochloride for relapsed or refractory solid tumors in younger patie…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) [Phase 2]
Phase 2 MATCH subprotocol F study evaluating crizotinib for cancers with ALK genetic changes. The trial is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies [Phase 1]
Phase 1 trial update of a genetically modified T-cell therapy targeting ROR1 in advanced malignancies, with terminated status and posted res…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations [Phase 2]
Phase 2 trial update comparing targeted drugs on tumor gene variations in advanced malignant solid neoplasms; results posted after completio…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W) [Phase 2]
Phase 2 MATCH-Subprotocol W trial evaluating AZD4547 for cancers with FGFR genetic alterations has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Tocilizumab for Patients With Cancer and COVID-19 Disease [Phase 2]
Phase 2 trial evaluating tocilizumab in cancer patients with COVID-19 was terminated; results were posted in June 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D) [Phase 2]
Phase 2 trial evaluating nivolumab in cancers with mismatch repair deficiency has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating talazoparib with temozolomide in younger patients with refractory or recurrent solid tumors; study completed with…
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma [Phase 1, Phase 2]
Clinical trial investigating crizotinib in children with relapsed or refractory solid tumors and anaplastic large cell lymphoma has complete…